Roth Capital Resumes Arcturus Therapeutics (ARCT) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

July 30, 2020 4:36 AM EDT
Get Alerts ARCT Hot Sheet
Price: $8.23 +4.71%

Rating Summary:
    13 Buy, 5 Hold, 3 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

Roth Capital analyst Elemer Piros resumes coverage on Arcturus Therapeutics (NASDAQ: ARCT) with a Buy rating and a price target of $77.00.


For an analyst ratings summary and ratings history on Arcturus Therapeutics click here. For more ratings news on Arcturus Therapeutics click here.


Shares of Arcturus Therapeutics closed at $53.17 yesterday.


You May Also Be Interested In





Related Categories

New Coverage